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Graphical abstract 
 
 
 
Briefs 
Base flipping of 2-aminopurine by the adenine-specific DNA methyltransferase M.TaqI was studied using X-
ray crystallography, time-resolved fluorescence spectroscopy of protein co-crystals as well as complexes in 
solution and acrylamide steady state fluorescence quenching 
 
Abstract 
We report the crystal structure of the DNA adenine-N6 methyltransferase, M.TaqI, complexed with DNA, 
showing the fluorescent adenine analog, 2-aminopurine, flipped out of the DNA helix and occupying virtually 
the same position in the active site as the natural target adenine. Time-resolved fluorescence spectroscopy of 
the crystalline complex faithfully reports this state: Base flipping is accompanied by the loss of the very short 
(~50 ps) lifetime component associated with fully base-stacked 2-aminopurine in DNA and 2-aminopurine is 
subject to considerable quenching by π-stacking interactions with Tyr108 in the catalytic motif IV (NPPY). 
This proves 2-aminopurine to be an excellent probe for studying base flipping by M.TaqI and suggests similar 
quenching in the active sites of DNA and RNA adenine-N6 as well as DNA cytosine-N4 methyltransferases 
sharing the conserved motif IV. In solution, the same distinctive fluorescence response confirms complete 
destacking from DNA and is also observed when the proposed key residue for base flipping by M.TaqI, the 
target base partner thymine, is substituted by an abasic site analog. The corresponding co-crystal structure 
shows 2-aminopurine in the active site of M.TaqI, demonstrating that the partner thymine is not essential for 
base flipping. However, in this structure, a shift of the 3' neighbor of the target base into the vacancy left after 
base flipping is observed, apparently replicating a stabilizing role of the missing partner thymine. Time-
resolved fluorescence and acrylamide quenching measurements of M.TaqI complexes in solution provide 
evidence for an alternative binding site for the extra-helical target base within M.TaqI, and suggest that the 
partner thymine assists in delivering the target base into the active site. 
Keywords 
DNA methyltransferase, M.TaqI, base 
flipping, nucleotide flipping, 2-aminopurine, 
time-resolved fluorescence, abasic site 
analog, acrylamide quenching, alternative 
binding site 
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1. Introduction 
DNA methyltransferases (MTases) catalyze the transfer of the activated methyl group from the ubiquitous 
cofactor S-adenosyl-L-methionine (AdoMet) to the target base within their recognition sequences. DNA 
MTases are divided into three groups, depending on their chemo- (adenine or cytosine) and regio- (N4 or C5 
of cytosine) selectivity: DNA adenine-N6, DNA cytosine-N4 and DNA cytosine-C5 MTases. All classes 
occur in prokaryotes e.g. as part of restriction-modification systems but in eukaryotes only DNA cytosine-C5 
MTases are found, where they play an important role in cell differentiation, transcriptional regulation of gene 
expression (gene silencing), genomic imprinting and carcinogenesis. (See 
1-11
 for recent comprehensive 
reviews). 
DNA MTases as well as many DNA glycosylases gain access to their target 2'-deoxyribonucleotide by base 
flipping (also called nucleotide flipping).
3,11 
The target nucleotides, which are inaccessible when buried within 
canonical B-DNA, are rotated out of the DNA helix and placed into the active sites of the enzymes where 
catalysis takes place. Base flipping was originally demonstrated by X-ray crystal structure analysis of the 
protein-DNA complex of the DNA cytosine-C5 MTase M.HhaI.
12
 More recently, flipping of adenine was 
demonstrated for the DNA adenine-N6 MTases M.TaqI
13
, T4 Dam
14
 and E.coli Dam
15
. M.TaqI methylates the 
target adenine within the double-stranded DNA sequence 5'-TCGA-3'. In the X-ray structure of the ternary 
complex between M.TaqI, DNA and the cofactor analog 5'-[2-(amino)ethylthio]-5'-deoxyadenosine (AETA) a 
closure of the two protein domains was observed with respect to the binary complex of M.TaqI with its 
cofactor or analogs
16
. Thus, the DNA bound between the two domains is compressed at the target base pair 
position and the target base partner thymine is shifted into the hole left by the flipped adenine, where it -
stacks with the 5'-neighbor guanine of the extrahelical target adenine. In this interstrand-stacked position, the 
partner thymine was interpreted to stabilize the apparent abasic site formed after target base flipping, as 
demonstrated in binding studies with M.TaqI and duplexes containing polycyclic aromatic DNA-base 
surrogates at the partner position.
17
 Furthermore, a push mechanism was proposed in which M.TaqI – by 
domain closure – pushes actively against the target base partner thymine, which in turn displaces the target 
adenine from the inside of the DNA helix.
18
 
However, it is not always possible to obtain evidence of base flipping by using X-ray crystallography, as 
crystals are not always obtainable. Therefore, spectroscopic methods have often been adopted. 2-Aminopurine 
(2Ap) is a fluorescent analog of adenine (6-aminopurine) and can form two Watson-Crick-like hydrogen 
bonds with thymine in DNA. Duplexes containing 2Ap-T base pairs instead of A-T base pairs have a very 
similar conformation and a slightly reduced thermal stability.
19-22
 The fluorescence properties of 2Ap respond 
to its molecular environment. Compared to the free fluorophore or 2Ap-ribonucleoside in aqueous solution, its 
fluorescence intensity is drastically quenched when incorporated in DNA due to base stacking interactions.
23
 
In this position it is buried inside the DNA and almost inaccessible to the solvent, as determined by 
acrylamide quenching experiments.
24
 However, when its base partner is missing and 2Ap faces an abasic site 
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analog, the fluorescence intensity and solvent accessibility rise due to an increased extra-helical population of 
2Ap.
24-26
  
The change in steady state 2Ap fluorescence intensity caused by destacking of 2Ap in labeled DNA has been 
used to detect and characterize base flipping by a range of DNA MTases.
27-39
 In almost all studies substitution 
of the target base by 2Ap gave the greatest increase in fluorescence intensity upon addition of enzyme. This is 
also true for the M.EcoP15I MTase (in the presence of Sinefungin), but replacement of a non-target adenine 
by 2Ap within the recognition sequence also led to a comparable increase in fluorescence intensity.
40
 
Furthermore, for the M.EcoRV MTase, the opposite was observed. 2Ap-substitution of another adenine within 
the recognition sequence, rather than the target adenine, gave the only detectable change in fluorescence 
intensity upon binding of the enzyme.
41,42
 Thus, conformational changes other than base flipping can lead to 
substantial changes in 2Ap fluorescence intensity. A change in steady state fluorescence intensity necessarily 
indicates changes in the environment of a fluorophore but the opposite is not necessarily true. Changes in the 
environment of a fluorophore may not be apparent in the steady state fluorescence intensity.  
However, time-resolved fluorescence spectroscopy gives a more detailed picture of the environment around a 
fluorophore. A fluorophore in a homogenous environment exhibits one lifetime; its fluorescence decay is 
mono-exponential. The decay is multi-exponential if the fluorophore is partitioned between several 
environments or conformations that provide distinctly different quenching efficiencies. A shorter lifetime 
indicates that the fluorophore is more efficiently quenched. As an example free 2Ap (2'-deoxy)ribonucleoside 
in aqueous solution possesses a high quantum yield and a lifetime of ~10 ns.
43-46
 It has been shown that 2Ap, 
when incorporated in DNA, exists in (three to) four distinguishable states of which the predominant one is the 
intra-helical, -stacked, highly quenched (low quantum yield) state with a lifetime of tens of 
picoseconds.
20,25,47,48
 
Recently, Neely et al. used time-resolved fluorescence spectroscopy to investigate the decays of 2Ap 
fluorescence of several 2Ap-labeled DNA duplexes alone and when bound to the DNA cytosine-C5 MTase 
M.HhaI or its T250G
28
 variant.
48
 They reported a dramatic decrease of the fractional amplitude of the shortest 
lifetime assigned to the intra-helical state in DNA upon binding of M.HhaI T250G when 2Ap was at the target 
position. In a single crystal containing 2Ap-labeled DNA complexed with M.HhaI T250G and S-adenosyl-
L-homocysteine (AdoHcy, the cofactor product formed after methyl group transfer), the lifetime 
corresponding to the intra-helical state of 2Ap was completely absent and the crystal structure shows that the 
2Ap was extra-helical. Hence, this destacking fluorescence response constitutes an unambiguous signature of 
base flipping. However, the crystal structure shows that 2Ap is not located in the active site but binding 
occurred in a remote position. 
Here, we report the crystal structures and time-resolved fluorescence spectroscopy of ternary complexes 
between M.TaqI, the cofactor analog AETA and two different 2Ap-substituted DNA duplexes. One duplex, in 
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which 2Ap is paired with thymine, mimics the natural substrate, whereas in the second duplex, thymine is 
replaced by a stable abasic site analog to elucidate the role of the partner thymine in base flipping. In parallel 
with these studies of 2Ap in structurally-defined, crystalline environments, complementary time-resolved 
fluorescence measurements were made on the free DNA duplexes and their binary and ternary M.TaqI 
complexes in solution. Acrylamide quenching experiments of the steady state fluorescence of 2Ap were 
performed to further characterize the solvent accessibility of 2Ap in the two binary solution complexes.  
 
2. Materials and Methods 
Materials. Synthesis and purification of oligodeoxynucleotides (ODN) is detailed in the Supporting 
Information. Duplexes (see Table 1 for sequences) were formed by heating complementary ODN in binding 
buffer (20 mM Tris/HOAc, 10 mM Mg(OAc)2, 50 mM KOAc, 1 mM DTT, 0.01% Triton X-100, pH 7.9) 
without Triton X-100 (at least 10 µM) or crystallization buffer (vide infra) to 95°C and slow cooling to room 
temperature within 2–3 h. For the solution measurements a 50% excess of the non fluorescent ODN was used 
to ensure complete annealing of the 2Ap-labeled ODN. 
 
Table 1. Abbreviations and sequences of DNA duplexes. M represents N6-methyladenine, 2Ap 
2-aminopurine and D a 1,2-dideoxy-D-ribose abasic site analog. The palindromic 5'-TCGA-3' recognition 
sequence of M.TaqI (separated by space from the rest of the sequence) contains two symmetry related target 
bases and by placing M at one target position (hemimethylated duplex) M.TaqI binding is oriented for 
flipping the other target base. For 10-A/T, numbering is included and the target adenine (A6) and its base 
partner thymine (T15) are highlighted. The 3' neighbor thymine (T7) and the 5' neighbor guanine (G5) of the 
target base, which -stack in complex B of the 10-2Ap/D·M.TaqI·AETA crystal structure (T7 shift), are 
underlined. 
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M.TaqI was overexpressed and purified as described before.
13,27
 Concentration of M.TaqI was estimated by 
the method of Bradford
49
 or by UV absorption at 280 nm using an extinction coefficient of 86,600 L mol
-1
 cm
-
1
. 5'-[2-(amino)ethylthio]-5'-deoxyadenosine (AETA) was synthesized from 5'-chloro-5'-deoxyadenosine by 
nucleophilic substitution with cysteamine. 
 
Crystallization. Crystallization of ternary M.TaqI complexes for X-ray crystallography and time-resolved 
fluorescence measurements was achieved as described for M.TaqI in complex with 10-A/T and AETA
13
 with 
some modifications detailled in the Supporting Information.  
 
Data collection and structure determination. Co-crystals with dimensions of 10 × 10 × 100 µm
3
 to 10 × 30 
× 100 µm
3
 were harvested with a nylon fiber loop from a drop, transferred quickly into a cryo protection 
solution (12% PEG6000 for 10-2Ap/T·M.TaqI·AETA or 12% PEG8000 10-2Ap/D·M.TaqI·AETA, 17.1% 
glycerol, 200 mM NaCl, 100 mM Tris/HCl, pH 7.3) and frozen in liquid nitrogen. Loops containing co-
crystals were placed onto goniometer heads and X-ray diffraction data were collected using a synchrotron 
beam source (European Synchrotron Radiation Facility, ESRF, Grenoble, France, see Table S1 of the 
Supporting Information for details on beamlines and detectors) under a nitrogen stream at 100 K. 
Data processing was performed using the programs XDS/XSCALE
50
 and data statistics are given in Table S1. 
Phase determination of the structure amplitudes was achieved by molecular replacement. For the 
10-2Ap/T·M.TaqI·AETA complex the structure of the 10-A/T·M.TaqI·AETA complex
13
 excluding the target 
adenine, AETA and water molecules was used as the initial model. The structure of the 
10-2Ap/T·M.TaqI·AETA complex with omitted target 2Ap, partner thymine, AETA and water molecules 
then served as the initial model for the 10-2Ap/D·M.TaqI·AETA complex. Structure refinement was 
performed with the program CNS
51
 and REFMAC5 from the CCP4 suite
52
 and electron density interpretation 
was carried out using O
53,54
 and Coot
55
. Structural figures were generated with DeepView/Swiss-PdbViewer 
v3.7
56
 or VMD 1.8
57
. 
 
Time-resolved fluorescence spectroscopy. Time-resolved fluorescence spectroscopy was performed using 
the technique of time-correlated single photon counting, using the same general procedure reported previously 
for the M.HhaI DNA MTase.
48
 The excitation source was the third harmonic of the pulse-picked output of a 
Ti-Sapphire femtosecond laser system (Coherent, 10 W Verdi and Mira Ti-Sapphire), consisting of pulses of 
~200 fs at 4.75 MHz repetition rate, with 320 nm wavelength. Fluorescence decays were measured in an 
Edinburgh Instruments spectrometer equipped with TCC900 photon counting electronics. The instrument 
response of the system was ~50 ps FWHM. Fluorescence decay curves were analyzed using a standard 
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iterative reconvolution method, assuming a multiexponential decay function. Decays were collected at several 
emission wavelengths (typically 370, 390 and 410 nm) and analyzed globally using Edinburgh Instruments’ 
FAST software, i.e. they were fitted simultaneously, with lifetimes, i, as common parameters (see Tables S3–
S10 in the Supporting Information). The quality of fit was judged on the basis of the reduced chi-square 
statistic, 2, and the randomness of residuals. 
Time-resolved fluorescence in the crystalline state: Co-crystals of M.TaqI were too small to allow 
fluorescence measurements to be made on a single crystal, so fluorescence was collected from many crystals 
of the same type (see Figure S1 of the Supporting Information). This required the development of a micro 
handling procedure for separating the small co-crystals from the mother liquor and washing them, as 
described in the Supporting Information.  
Time-resolved fluorescence in solution: Measurements were carried out with duplexes alone (2 µM 14-2Ap/T 
or 14-2Ap/D), in the presence of M.TaqI (8 µM) and additionally in the presence of AETA (1 mM) in binding 
buffer. The dissociation constants KD for the binary complexes 14-2Ap/T·M.TaqI and 14-2Ap/D·M.TaqI are 
11 nM and 0.3 nM, respectively, as determined by competitive steady state 2Ap fluorescence titrations
17
. The 
KD for the M.TaqI·AETA complex is 0.5 µM and was determined by displacement of the fluorescent cofactor 
analog 5'-[(3S)-3-((N-methylanthraniloyl)amino-3-carboxy)propylthio]-5'-deoxyadenosine from M.TaqI 
(unpublished result). Thus, the M.TaqI and AETA concentrations used are high enough to insure quantitative 
binding of the 2Ap-labeled duplexes in binary and ternary complexes.  
 
Steady state fluorescence acrylamide quenching: Titrations were performed by adding increasing amounts 
of solutions (120 µL) containing 2Ap 2'-deoxyribonucleotide (50 nM), 2Ap-labeled duplex (5 µM 14-2Ap/T; 
300 nM 14-2Ap/D) or 2Ap-labeled duplex and M.TaqI (300 nM 14-2Ap/T and 1500 nM M.TaqI; 50 nM 
10-2Ap/D and 250 nM M.TaqI) and acrylamide (3.12 M) in binding buffer to solutions (500 µL) of 2Ap 
2'-deoxyribonucleotide (50 nM), 2Ap-labeled duplex (5 µM 14-2Ap/T; 300 nM 14-2Ap/D) or 2Ap-labeled 
duplex and M.TaqI (300 nM 14-2Ap/T and 1500 nM M.TaqI; 50 nM 10-2Ap/D and 250 nM M.TaqI) in 
binding buffer, respectively. Each data point was background corrected by subtraction of the fluorescence 
obtained in a parallel titration without the 2Ap containing compound. Satisfactory fits to the data were 
obtained by assuming two populations (a and b) of 2Ap (except for the 2Ap 2'-deoxyribonucleotide) and 
using the equation 
F / F0 = A0a / (1 + Ka [Q]) + A0b / (1 + Kb [Q]),   (Eq. 1) 
where the fitted parameters A0a,b and Ka,b are the fractions of steady state fluorescence intensities without 
quencher and the quenching constants, respectively, of the populations a and b. F and F0 are the fluorescence 
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intensity in the presence and absence of quencher, respectively, and [Q] is the concentration of the quencher 
acrylamide. 
 
3. Results and Discussion 
The co-crystal structures of two 2Ap-labeled 10 bp DNA duplexes (see Table 1 for sequences) in complex 
with the DNA adenine-N6 MTase M.TaqI and the non-reactive cofactor analog AETA have been determined. 
In both duplexes, adenine at the target position of M.TaqI is replaced by 2Ap. In duplex 10-2Ap/T, 2Ap is 
paired with thymine, whereas in duplex 10-2Ap/D, 2Ap is opposite the abasic site analog 1,2-dideoxy-
D-ribose (D). The fluorescence decays of both crystalline systems have been measured, together with those of 
the duplexes and their binary and ternary M.TaqI complexes in solution. Acrylamide steady state fluorescence 
quenching has been used to determine the solvent accessibility of 2Ap in various systems.  
 
3.1. The environment of 2Ap in the active site of M.TaqI 
3.1.1. Crystal structure of the 10-2Ap/T·M.TaqI·AETA complex 
The complex of 10-2Ap/T with M.TaqI and AETA (10-2Ap/T·M.TaqI·AETA) shows the same overall 
structure as the previously determined structure of 10-A/T complexed with M.TaqI and AETA
13
 
(10-A/T·M.TaqI·AETA). (See Tables S1 and S2 of the Supporting Information for crystallographic details 
and r.m.s. deviations, respectively). Both are indexed in space group P 21 and thus have two symmetry 
independent, yet similar, complexes in the asymmetric unit (complex A and B). 
In 10-2Ap/T·M.TaqI·AETA, 2Ap is flipped into the active site like adenine in 10-A/T·M.TaqI·AETA and the 
hole left by the flipped base is occupied by the target base partner thymine (T15, Figure 1a). As illustrated in 
Figure 2, 2Ap is bound in the active site in a very similar fashion to the canonical base adenine. Like adenine, 
2Ap is -stacked with Tyr108 but due to the different position of the exocyclic amino group, it lacks the face-
to-edge aromatic interaction to Phe196 and the hydrogen bond to Pro106/O. A small shift of 2Ap with respect 
to adenine brings 2Ap/N7 closer to Tyr108/N which probably leads to a stronger hydrogen bond. Asn105 
forms different hydrogen bonds to 2Ap than to adenine. To optimize hydrogen bond distances, the positions 
of O and N of Asn105 were interchanged with respect to the 10-A/T·M.TaqI·AETA structure13 and 
positioned as in the binary complexes of M.TaqI and AdoMet, AdoHcy or Sinefungin
16
. This allows a 
hydrogen bond to be formed between N of Asn105 and N1 of 2Ap. Another weak hydrogen bond may be 
present between N2 of 2Ap and O of Asn105. Additionally, we interpreted the electron density of the side 
chain of Lys199 in complex B to represent two different conformations (about 50% each), indicating 
flexibility of Lys199. 
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Figure 1. Crystal structures showing 2Ap in the active site of M.TaqI. a: 2.4 Å crystal structure of the 
10-2Ap/T·M.TaqI·AETA complex (complex B) with the target base partner thymine (T15) occupying the 
hole left by the flipped base and -stacking with G5, the 5' neighbor of the target base (magnified view in 
inset on the left). b: 1.7 Å crystal structure of the 10-2Ap/D·M.TaqI·AETA complex (complex B, D15 abasic 
site analog) with the target base 3' neighbor thymine (T7) occupying the hole left by the flipped target base 
and -stacking with G5 (magnified view in inset on the right). The secondary structural elements of M.TaqI 
are shown in blue, the cofactor analog AETA in yellow, the DNA in green and the extra-helical 2Ap 
2'-deoxyribonucleotide, its base partner (T15 or D15) and the 3' neighbor thymine (T7) in red. 
 
 
Figure 2. Comparison of the positions of 2Ap and adenine in the active site of M.TaqI. The stereo 
representation shows the superposition of 2Ap in complex A of 10-2Ap/T·M.TaqI·AETA (purple) and 
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adenine in complex A of 10-A/T·M.TaqI·AETA (green, PDB ID code 1G38) in the active site of M.TaqI. The 
hydrogen bonds formed by 2Ap or adenine are indicated as dotted, black lines. Superposition was performed 
using all protein backbone atoms resulting in the r.m.s. deviations reported in Table S2. 
 
In the previously described ternary DNA·M.HhaI(T250G)·AdoHcy complex containing 2Ap at the target 
site,
48
 the position of the flipped-out 2Ap differs from that found for the natural target base cytosine and other 
bases or analogs at the target position in ternary M.HhaI structures (PDB ID codes 1MHT
12
, 3-4MHT
58
, 
5MHT
59
, 6MHT
60
, 7-8MHT
61
, 1FJX
28
, 1M0E
62
). Consequently, the local environment reported by the 
fluorescence response of 2Ap does not reflect that experienced by the natural base in the M.HhaI active site. 
In the case of the M.TaqI base-flipped complex, however, the similarity of the positions of 2Ap and adenine 
means that the fluorescence decay of 2Ap will faithfully report the interactions of the natural base within the 
active site of M.TaqI. 
 
3.1.2. Time-resolved fluorescence of 10-2Ap/T·M.TaqI·AETA in the crystalline state 
The 10-2Ap/T·M.TaqI·AETA crystals show a multi-exponential fluorescence decay, requiring three lifetime 
components to give a satisfactory fit. This indicates that the ternary complex exists in a number of 
conformational states in which 2Ap experiences different interactions and hence different quenching rates. 
This is similar to the behavior observed previously for DNA-M.HhaI crystalline complexes
48
. The 
fluorescence lifetimes and their fractional amplitudes are given in Table 2 and plotted in Figure 3a. In a simple 
interpretation, each lifetime can be considered to represent a distinct conformational state and the fractional 
amplitude indicates the occupancy of this state. (In fact, each lifetime is likely to represent a distribution of 
conformations in which 2Ap experiences similar quenching rates.) It can be seen that although three lifetimes 
are needed to accurately describe the emitting species, the two shorter 0.93 and 2.3 ns lifetimes (2, 3) with 
fractional amplitudes of 0.46 and 0.51, respectively, account for the vast majority of the population. The 
minor 8.6 ns lifetime component (4) is due to 2Ap in an unquenched environment, only 3% of ternary 
complexes are in this conformation. In the predominant conformations, 2Ap is substantially quenched by 
intermolecular interactions. Lifetimes of similar magnitude to these are observed for 2Ap within the DNA 
helix, where they are attributed to imperfectly stacked conformations in which quenching of 2Ap is less 
efficient than in the highly stacked, major conformation of the duplex that typically has a lifetime of the order 
of 100 ps or less (vide infra).
20,25,47,48
 Such ‘intermediate’ lifetimes of ~1-3 ns have also been observed with 
large fractional amplitude on addition of the natural nucleosides to a solution of 2Ap 2'-deoxyribnuleoside.
45 
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Figure 3. Graphical representation of the response of the 2Ap fluorescence decay parameters to base flipping. 
a: Plots of fractional amplitude (Ai) versus lifetime (i) for the crystalline 10-2Ap/T·M.TaqI·AETA complex 
(black crosses), the ternary 14-2Ap/T·M.TaqI·AETA complex in solution (green triangles), the binary 
14-2Ap/T·M.TaqI complex in solution (red squares) and the free 14-2Ap/T duplex in solution (blue 
diamonds). The inset shows the respective decays following the same color code. b: Analogous plots for the 
crystalline 10-2Ap/D·M.TaqI·AETA complex, the free 14-2Ap/D duplex and its binary and ternary 
complexes in solution, following the same color code. The connecting lines are for illustrative purposes only. 
 
Table 2. Fluorescence lifetimes (i, i = 1–4) and their fractional amplitudes (Ai) for the crystalline (C) ternary 
complexes (10-2Ap/T·M.TaqI·AETA and 10-2Ap/D·M.TaqI·AETA), the free 14-2Ap/T and 14-2Ap/D 
duplexes, their binary complexes with M.TaqI (14-2Ap/T·M.TaqI and 14-2Ap/D·M.TaqI), and their ternary 
complexes with M.TaqI and AETA (14-2Ap/T·M.TaqI·AETA and 14-2Ap/D·M.TaqI·AETA), in buffered 
aqueous solution (S). Decays collected at several emission wavelengths were analyzed globally to give the 
reported lifetimes (Tables S3–S10). The fractional amplitudes show little variation with emission wavelength 
and those for 390 nm (or 380 nm) emission are given. The calculated quantum yield relative to that of free 
2Ap ribonucleoside in water (rel) is also given. For the long lifetime component (τ4), its fractional 
contribution to the steady state fluorescence intensity, (F4) is given, where F4 = A4 4 / (). 
 C
 
S
 τ1/ ns τ2/ ns τ3/ ns τ4/ ns A1 A2 A3 A4 (F4) rel
a
 
10-2Ap/T·M.TaqI·AETA X  - 0.93 2.3 8.6 - 0.46 0.51 0.03 (0.14)  0.18 
14-2Ap/T·M.TaqI·AETA  X - 0.55 1.9 7.3 - 0.54 0.38 0.08 (0.36)  0.15 
14-2Ap/T·M.TaqI  X - 0.41 1.9 7.3 - 0.21 0.66 0.13 (0.41)  0.21 
14-2Ap/T  X 0.03 0.57 2.4 7.8 0.81 0.06 0.09 0.04 (0.53) <0.055 
10-2Ap/D·M.TaqI·AETA X  - 0.92P 2.3 7.6 - 0.44 0.48 0.08 (0.29)  0.21 
14-2Ap/D·M.TaqI·AETA  X - 0.28 2.8 9.6 - 0.33 0.30 0.37 (0.79)  0.42 
14-2Ap/D·M.TaqI  X - 0.23 3.3 9.7 - 0.26 0.18 0.56 (0.89)  0.57 
14-2Ap/D  X 0.04 0.26 2.5 8.3 0.62 0.18 0.09 0.11 (0.76) <0.11 
a
For the free duplexes, the rel value quoted is an upper limit as there may be lifetime components shorter than 
30 ps present that are beyond the time resolution of our measurements. 
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The exact nature of the interbase interactions or conformational states responsible for these intermediate 
lifetimes in DNA or quenched nucleosides remains unclear. However, the interactions responsible for 
quenching of 2Ap in the M.TaqI active site are revealed by the crystal structure which shows that 2Ap is 
-stacked face to face with Tyr108 and is in close proximity to Phe196. As a result of interactions with these 
aromatic residues (in particular Tyr108) the fluorescence quantum yield for flipped out 2Ap, relative to free 
2Ap riboside in aqueous solution, is only 0.18. This is significantly different to what was previously observed 
for the crystalline ternary DNA·M.HhaI(T250G)·AdoHcy complex containing 2Ap at the target position,
48
 
where the dominant lifetime is 10.9 ns (fractional amplitude 0.76). In M.HhaI, there are no aromatic residues 
in proximity to the flipped base and the quantum yield relative to free 2Ap is 0.9.  
The heterogeneity apparent in the fluorescence decay of 2Ap may be related to the two symmetry independent 
complexes A and B in the asymmetric unit, which have different positions of Lys199 and slightly different 
positions of Phe196 in close proximity to 2Ap (Figure 4a). However, it cannot be ruled out that the lifetime of 
2Ap is affected by conformational heterogeneity that is unresolved in the crystal structure. The long lifetime 
component has such a small fractional amplitude (0.03) that its corresponding conformations cannot be 
observed in the crystal structure due to the small contribution to the electron density. 
 
 
Figure 4. Comparison of the active site structures of complex A and complex B, for 
10-2Ap/T·M.TaqI·AETA, 10-2Ap/D·M.TaqI·AETA and 10-A/T·M.TaqI·AETA. a: 2Ap and selected active 
site residues of complex A (purple) are superposed on those of complex B (light blue), from the 2.4 Å crystal 
structure of the ternary 10-2Ap/T·M.TaqI·AETA complex. The electron density (1.5 ) is shown for complex 
A, only. b: The same superposition for complex A (orange) and B (red) of 10-2Ap/D·M.TaqI·AETA (1.7 Å 
resolution, electron density at 2.0 ). c: The same superposition for complex A (light green) and B (dark 
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green) of 10-A/T·M.TaqI·AETA (2.0 Å resolution, electron density at 1.5 , PDB ID code 1G38). 
Superposition of the complexes A and B, respectively, was performed using all protein backbone atoms 
resulting in the r.m.s. deviations reported in Table S2. 2Ap and the NPPY motif (of which Tyr108 is omitted 
for clarity) fit almost perfectly, whereas small differences between complexes A and B can be observed for 
Phe196 and Lys199. 
 
DNA adenine-N6 MTases and DNA cytosine-N4 MTases share the conserved catalytic motif IV 
(D/N/S)PP(Y/F/W)
63
 where the aromatic residue in M.TaqI is Tyr108. Interestingly, these enzymes have 
overlapping target base specificities.
64,65
 The fact that adenine can be methylated by a DNA cytosine-N4 
MTase proves that it can be positioned in a catalytically competent conformation within the active site, 
probably similar to the target adenine in DNA adenine-N6 MTases. Thus, it is likely that 2Ap takes a similar 
position within motif IV of DNA cytosine-N4 MTases as in the present 10-2Ap/T·M.TaqI·AETA structure. 
Additionally, RNA adenine-N6 MTases, which can double-methylate their target adenine at N6, possess a 
very similar catalytic motif IV (N/S)(I/L/V)P(Y/F).
66
 So it is expected that 2Ap will be subject to similar 
quenching interactions in the active sites of other DNA or RNA adenine-N6 MTases as well as DNA cytosine-
N4 MTases.  
 
3.1.3. Time-resolved fluorescence of 10-2Ap/T and its binary or ternary complexes with M.TaqI in 
solution 
For the studies in solution we used a 14 bp DNA duplex exhibiting the same base pairs surrounding 2Ap-T as 
in the 10 bp duplex in the crystals: Three base pairs at the 5' side and two base pairs at the 3' side of 2Ap are 
identical (Table 1). Additionally, purines and pyrimidines occur at corresponding positions within the two 
duplexes. The lifetimes of the systems in solution, which spanned the free DNA 14-2Ap/T, the binary 
14-2Ap/T·M.TaqI complex and the ternary 14-2Ap/T·M.TaqI·AETA complex are listed in Table 2 and 
graphically summarized in Figure 3a.  
The fluorescence decay for the free 14-2Ap/T duplex is multi-exponential, requiring four lifetime components 
to give a satisfactory fit (Table 2 and Figure 3a), indicating the existence of four conformational states, as seen 
in previous studies of 2Ap-labeled DNA
20,47,48
. The predominant, very short lifetime (1) of 30 ps with a 
fractional amplitude of 0.81 is characteristic of 2Ap in a fully stacked conformation, in which it is subject to 
efficient charge transfer quenching from its adjacent guanine stacking partner.
67,68
 The intermediate lifetimes 
(2 and 3, imperfectly stacked conformations) constitute 15% of the population, while the fraction exhibiting 
the longest lifetime (4) corresponding to solvent-exposed, extra-helical 2Ap, as confirmed by acrylamide 
quenching experiments (vide infra), accounts for only 4% of the population. 
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Binding of M.TaqI to 14-2Ap/T results in a profound change in the 2Ap fluorescence decay, as shown in 
Table 2 and Figure 3a. The short lifetime (1) attributed to fully stacked 2Ap in DNA is completely absent in 
the binary complex. This response to base flipping is much clearer than that recently seen for the T250G 
mutant of M.HhaI, for which ~16–19% of a short lifetime (~150 ps) remained in the binary and ternary 
complexes in solution.
48
  
Comparison of the decay parameters of the binary and ternary complexes in solution shows the effect of 
binding of the cofactor analog, AETA. While the lifetimes are almost identical, there is a difference in the 
fractional amplitudes. This suggests that essentially the same conformations exist in both complexes, but 
binding of AETA changes the relative population of conformational states: the population of the most 
quenched conformation (2) increases, while the populations of the less quenched conformations (3 and 4) 
decrease. 
The similarity between the decay parameters of the ternary 14-2Ap/T·M.TaqI·AETA complex in solution and 
the crystalline 10-2Ap/T·M.TaqI·AETA complex, as illustrated graphically in Figure 3a, shows that the 
fluorescence response of 2Ap provides a definitive indication of base flipping by M.TaqI in solution. The 
lifetimes, although clearly indicative of similar environments, are somewhat shorter in solution than in the 
crystal. This could be due to greater mobility of 2Ap within the active site and is in line with the observation 
that the excited state decay of 2Ap in duplexes is influenced by base dynamics,
67,68,69
 but could also indicate 
that 2Ap partly occupies imperfectly -stacked positions within DNA in the M.TaqI complexes in solution. 
Nevertheless, the active site of the ternary M.TaqI complex in solution necessarily needs to be populated by 
2Ap to crystallize in the observed structure.  
 
3.2. Influence of the target base partner on base flipping 
The target base partner thymine is believed to have a key role in base flipping by M.TaqI for two reasons, (i) 
stabilization of the apparent abasic site left by the target base after base flipping
13,17
 and (ii) pushing (mediated 
by domain closure of M.TaqI) the target base out of the DNA.
18
 To gain deeper insight into the mechanistic 
role of the target base partner, we investigated the interaction of M.TaqI with a duplex, 10-2Ap/D (sequence 
shown in Table 1) in which 2Ap is placed at the target position and opposite to the chemically stable abasic 
site analog 1,2-dideoxy-D-ribose, D. 
 
3.2.1. Structure and time-resolved fluorescence of the crystalline 10-2Ap/D·M.TaqI·AETA complex 
The overall co-crystal structure of the complex of 10-2Ap/D with M.TaqI and AETA 
(10-2Ap/D·M.TaqI·AETA) is again very similar to that of 10-A/T·M.TaqI·AETA, with two symmetry 
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independent complexes (A and B) in the asymmetric unit (see Table S1 for crystallographic details and S2 for 
r.m.s. deviations). In this structure, 2Ap is also found in the active site and in the same position as in the 
10-2Ap/T·M.TaqI·AETA structure (Figure 1b and Figure 4b), which indicates that the partner thymine is not 
obligatory for target base flipping.  
In complex A no major structural differences are observed compared to 10-2Ap/T·M.TaqI·AETA and the 
hole left by the flipped base is simply filled by water. However, a profound structural difference is observed in 
complex B, where the hole left by the flipped base (that is occupied by the partner thymine, T15, in the 
10-A/T·M.TaqI·AETA and 10-2Ap/T·M.TaqI·AETA structures) is filled by the 3' neighbor thymine (T7) of 
the target base. A similar base shift has been observed in the DNA-protein co-crystal structure of the DNA 
cytosine-C5 MTase M.HaeIII.
70
 As illustrated in Figure 1b (see also Figure S2 of the Supporting Information 
for details), T7 is -stacked to the 5' neighbor guanine (G5) of the extra-helical target base in a similar fashion 
to the partner thymine (T15) in the 10-A/T·M.TaqI·AETA or 10-2Ap/T·M.TaqI·AETA co-crystal structures. 
The T7 shift could be an alternative way to stabilize the apparent abasic site formed upon target base flipping. 
Such a T7 shift is also observed in the analogous co-crystal structure with a duplex containing the canonical 
target adenine opposite to the abasic site analog (10-A/D·M.TaqI·AETA, unpublished results). 
The decay parameters of the ternary crystalline 10-2Ap/D·M.TaqI·AETA complex (Table 2 and Figure 3b) 
are similar to those of the analogous 10-2Ap/T·M.TaqI·AETA complex, indicating that 2Ap experiences 
similar quenching interactions in the active site. This spectroscopic result mirrors the similar environments of 
2Ap observed in the two crystal structures (Figure 4). 
 
3.2.2. Time-resolved fluorescence of 10-2Ap/D and its binary and ternary complexes with M.TaqI in 
solution 
The fluorescence decay parameters of the free 14-2Ap/D duplex resemble those of free 14-2Ap/T. The very 
short lifetime (1) has a lower fractional amplitude in the free 14-2Ap/D duplex (0.62) than in the free 
14-2Ap/T duplex (0.81) and the long lifetime (4) has a greater amplitude (0.11 compared with 0.04). Thus, in 
the absence of the partner thymine, 2Ap has a greater tendency to exist in an extra-helical state, but the major 
fraction is still found in a fully -stacked conformation. A similar trend has been observed before25 and 
probably reflects the missing Watson-Crick-like hydrogen bonds and a lack of continuous base stacking in the 
complementary strand. 
Most interestingly, the very short lifetime component is also absent in the 14-2Ap/D·M.TaqI and 
14-2Ap/D·M.TaqI·AETA complexes in solution (Table 2), demonstrating that 2Ap has been flipped out of 
the duplex and confirming that the partner thymine is not essential for base flipping in these complexes. 
Although it should be thermodynamically easier to flip 2Ap from the 14-2Ap/D than from the 14-2Ap/T 
Page 15 of 23 
duplex, the time-resolved fluorescence data clearly show that the major fraction of 2Ap is -stacked in 
14-2Ap/D and these -stacking interactions need to be overcome during the base flipping process. However, 
in the 14-2Ap/D duplex the partner thymine is missing and, thus, it can not be utilized to actively push out the 
target base via a M.TaqI-mediated DNA compression. In fact, steady state fluorescence stopped-flow data 
indicate that M.TaqI-induced 2Ap flipping from 14-2Ap/D is more than twofold faster than from 14-2Ap/T 
(unpublished results). DNA compression occurs perpendicular to the helix axis while the 3' neighbor thymine 
(T7) shift observed in complex B of the 10-AP/D·M.TaqI·AETA structure is almost parallel to the helix axis. 
Thus, the 3' neighbor thymine (T7) is not expected to replicate/rescue a pushing function of the partner 
thymine. However, the T7 shift could lead to a stabilization of the extra-helical target base by binding into the 
cavity left in the DNA. So the role of the target base partner seems less likely to be part of an active push 
mechanism, but rather to stabilize the extra-helical target base conformation by binding to the apparent abasic 
site after target base flipping. 
Apart from the absence of the short lifetime, the decay parameters of the 14-2Ap/D complexes in solution 
differ significantly from those of the crystalline 10-2Ap/D·M.TaqI·AETA complex. In solution, there is a 
highly populated unquenched conformation (4, fractional amplitude 0.37 in the ternary and 0.56 in the binary 
complex) with lifetimes of 9.6–9.7 ns, which is in contrast to the crystalline complex in which the unquenched 
conformation accounts for only 8% of the population. Thus, the crystalline system, in which 2Ap is located in 
the M.TaqI active site, appears to represent only a subset of the conformations present in solution; there exists 
at least another highly populated conformation in solution in which 2Ap has been flipped out of the duplex 
(absence of 1) but exhibits a long lifetime and, thus, is not located within the quenching environment of the 
active site of M.TaqI. In this respect, the 14-2Ap/D complexes in solution also differ from the 14-2Ap/T 
complexes in solution; the latter have much lower fractional amplitudes of the long lifetime component and 
presumably exist predominantly in conformations with 2Ap located in the active site. Thus, the target base 
partner thymine appears to be important (albeit not obligatory) for delivering the target base into the active 
site of M.TaqI and avoiding catalytically incompetent conformations (vide infra). 
 
3.3. Evidence for an alternative binding site 
We were interested in further characterizing the conformation(s) within the M.TaqI complexes, in which 2Ap 
exhibits a long lifetime, approximating that of the free 2Ap (2'-deoxy)ribonucleoside in solution. It is 
important to be aware that the steady state fluorescence intensity is dominated by this long lifetime 
component; even in the unbound 14-2Ap/T duplex, where it constitutes only 4% of the emitting population, it 
is responsible for 53% of the steady state fluorescence intensity (Table 2). In the 14-2Ap/D duplex 76% 
(fractional amplitude 0.11), in the binary 14-2Ap/T·M.TaqI complex 41% (fractional amplitude 0.13) and in 
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the binary 14-2Ap/D·M.TaqI complex even 89% (fractional amplitude 0.56) of the steady state fluorescence 
in solution are caused by the long lifetime component.  
To establish the solvent accessibility of 2Ap, we performed steady state fluorescence acrylamide quenching 
experiments with the free duplexes and their respective complexes with M.TaqI and compared the results to 
free 2Ap 2'-deoxyribonucleotide. As can be inferred from the Stern-Volmer plots in Figure 5, the extent of 
quenching of 2Ap decreases in the order 2Ap 2'-deoxyribonucleotide >> 14-2Ap/D >> 14-2Ap/T > 
14-2Ap/T·M.TaqI ~ 14-2Ap/D·M.TaqI. Satisfactory fits to the data were obtained by assuming two 
populations of 2Ap, exhibiting different acrylamide quenching constants, in each case except for the 2Ap 
2'-deoxyribonucleotide (single population). The results are listed in Table 3. For the free duplexes, 14-2Ap/T 
and 14-2Ap/D, the percentage of steady state fluorescence exhibiting the larger quenching constant (similar to 
that for the free 2Ap 2'-deoxyribonucleotide) is in good agreement with the percentage of steady state 
intensity due to the long lifetime component obtained from time-resolved fluorescence measurements, as 
shown in Tables 3 and 2: 47% vs. 53% for 14-2Ap/T and 70% vs. 76% for 14-2Ap/D. In agreement with the 
results obtained by Stivers
24
 and Rachofsky et al.
25
, these results demonstrate that in the long-lifetime 
conformations of 14-2Ap/T and 14-2Ap/D, 2Ap is solvent-exposed. 
 
 
Figure 5. Stern-Volmer plots of fluorescence quenching of 2Ap by acrylamide (Q). The extent of quenching 
follows the order: 2Ap 2'-deoxyribonucleotide (squares) >> 14-2Ap/D (triangles) >> 14-2Ap/T (circles) > 
14-2Ap/T·M.TaqI (filled circles) ~ 14-2Ap/D·M.TaqI (filled triangles). The Stern-Vollmer plots of 
14-2Ap/T·M.TaqI and 14-2Ap/D·M.TaqI are magnified in the inset. The lines are fits of Eq. 1) to the data 
points. 
 
Table 3. Fitting results of the acrylamide quenching titration curves from Figure 5 assuming two different 
populations of 2Ap (a and b) in all cases except for free 2Ap 2'-deoxyribonucleotide (one population). A0a,b 
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and Ka,b are the percentage contributions to the steady state fluorescence intensities without quencher and the 
quenching constants, respectively, of the populations a and b. The larger the quenching constant Ka,b the more 
efficient the quenching and the more solvent accessible the population. (Errors are given as 2 standard 
deviation obtained from the fits.) 
 
In contrast, the 14-2Ap/T·M.TaqI and 14-2Ap/D·M.TaqI complexes behaved very differently. The percentage 
of steady state fluorescence from the populations of 2Ap with the larger quenching constant is almost 
negligible (~3%), although the conformations exhibiting the long lifetime contribute 41% and 89% to the 
steady state fluorescence in 14-2Ap/T·M.TaqI and 14-2Ap/D·M.TaqI, respectively. Therefore, in the long-
lifetime conformations of the M.TaqI-bound duplexes, 2Ap is not solvent exposed but exists in an 
unquenched, solution-like, polar environment, which is shielded by the enzyme. This leads us to propose an 
alternative binding site for the flipped base in M.TaqI, that is extra-helical from DNA but is not quenched by 
Tyr108 within the active site. Such an alternative binding site (exo site) has recently been identified for the 
base flipping hOGG1 DNA glycosylase with non cognate DNA by X-ray crystallography.
71
 A possible 
functional role of such an exo site in M.TaqI could be to preferentially bind methylated target adenine, 
providing a check point and avoiding double-methylation of adenine residues. Double-methylation is found 
for adenine-specific RNA di-MTases, however, in DNA, it would abolish Watson-Crick base pairing and 
could introduce unwanted mutations.  
 
4. Conclusions 
The crystal structures of the ternary M.TaqI complexes with both DNA duplexes, 10-2Ap/T and 10-2Ap/D, 
show that 2Ap is flipped into the active site of M.TaqI and occupies a position similar to that found previously 
for the natural target base, adenine
13
. Thus, 2Ap can be considered an accurate mimic of the natural target 
base adenine for M.TaqI and most likely for other DNA and RNA adenine-N6 or DNA cytosine-N4 MTases 
containing the conserved catalytic motif IV as well. The fluorescence of 2Ap is strongly quenched in the 
M.TaqI active site, mainly as a result of -stacking interaction with the conserved aromatic amino acid side 
chain of Tyr108. Thus, base flipping is not synonymous with elimination of quenching, as is often assumed. 
Conformational heterogeneity evident in the fluorescence decay of 2Ap in the active site can be related to 
structural heterogeneity in the crystal associated with the two symmetry-independent M.TaqI complexes in the 
 Ka / M
-1 
Kb / M
-1
 A0a / % A0b / % 
2Ap 2Ap'-deoxyribonucleotide  26.9 ± 0.9  100.0 ± 1.0  
14-2Ap/T  33.2 ± 2.0 0.17 ± 0.04  46.7 ± 0.9 53.3 ± 1.0 
14-2Ap/D  24.8 ± 0.7 3.57 ± 0.20  70.1 ± 1.5 29.9 ± 1.6 
14-2Ap/T·M.TaqI 132.6 ± 42.3 0.38 ± 0.006   2.7 ± 0.2 97.3 ± 0.2 
14-2Ap/D·M.TaqI  58.7 ± 11.2 0.05 ± 0.005   3.3 ± 0.2 96.7 ± 0.2 
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asymmetric unit. The fluorescence decay parameters of the ternary 14-2Ap/T complex in solution resemble 
those of the crystalline complex, indicating that 2Ap is also flipped into the active site of M.TaqI in solution. 
Base flipping by M.TaqI is accompanied by the complete loss of the very short lifetime component that is 
characteristic of fully stacked intra-helical 2Ap in DNA, which is far clearer than observed previously for 
M.HhaI
48
. The fluorescence decay of 2Ap provides a clear signal of base flipping by M.TaqI and will be 
useful for studying base flipping in other DNA adenine-N6 and DNA cytosine-N4 MTases. 
Two main functions in base flipping have been attributed to the target base partner: (i) stabilization of the 
extra-helical target base conformation by occupying the resulting apparent abasic site in DNA and (ii) pushing 
the target base out of the DNA helix upon domain closure of M.TaqI. The crystal structure of the 
10-2Ap/D·M.TaqI·AETA complex and time-resolved fluorescence data of binary and ternary 14-2Ap/D 
complexes in solution, show that base flipping can occur even in the absence of the partner thymine, casting 
doubt on these functional roles. However, the crystal structure shows that stabilization of the extra-helical 
target base can be replicated by repositioning of the 3' neighbor thymine into the apparent abasic site formed 
after base flipping whereas this 3' neighbor shift is not expected to exert a push on the target base because it 
occurs perpendicular to the domain closure of M.TaqI. 
The fluorescence decays of the binary and ternary 14-2Ap/D complexes in solution show that, although 2Ap 
is entirely flipped out of the DNA, a substantial fraction of this extra-helical 2Ap is not located in the 
quenching environment of the active site of M.TaqI. Acrylamide quenching experiments suggest the existence 
of an alternative binding site in which 2Ap is buried within M.TaqI and inaccessible to the solvent. This site, 
which could be an intermediate in the flipping pathway, is also occupied by 2Ap in the 14-2Ap/T complexes 
but to a much lesser extent. Thus, although not essential for pushing the target base out of the helix, the target 
base partner thymine is important in delivering the target base into the active site. 
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